HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics sales grew 11.9% to $10.5 bil. in 1999 and profit before taxes and employee sharing rose 13.2% to $1.12 bil. Dermatology sales jumped 31.6% to $199 mil. Consolidated worldwide sales increased 12.1% to $10.77 bil. in 1999, and net profits before capital gains/losses jumped 15.3% to $698 mil. Sales growth is based on pro forma figures, excluding Synthelabo, which merged with Sanofi in 1999. L'Oreal sales achieved a 4% positive structural impact due to the consolidation of cosmetics and dermatology subsidiaries in the U.S

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007703

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel